Skip to content

Blind Fascia Iliaca Compartment Block Compared to Ultrasound-guided Femoral Nerve Block in Patients With Hip Fractures

Analgesic Effect of Blind Fascia Iliaca Compartment Block Compared to an Ultrasound-guided Femoral Nerve Block in Patients With Hip Fractures

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05365555
Enrollment
100
Registered
2022-05-09
Start date
2022-05-01
Completion date
2023-04-30
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fractures

Brief summary

The goal of this study is to compare the analgesic effect of a blind fascia iliaca compartment block to an ultrasound-guided femoral nerve block in patients that present to the emergency department with hip fractures.

Detailed description

Hip fractures often present to the emergency department and elderly, already fragile, patients are overrepresented. The pain associated with a hip fracture can be severe and have deleterious effects on the patient. Many studies, and a Cochrane review, have shown that a peripheral nerve block provides good pain relief and has many benefits compared to traditional pain relief, such as intravenous morphine. There is less consensus regarding which kind of nerve block, and which technique, is best to use. Many studies compared different kinds of nerve blocks to traditional methods, or more recently compared different kinds of ultrasound-guided techniques to each other. This study proposes to compare the widely used technique of a blind fascia iliaca compartment block (FICB) to an ultrasound-guided femoral nerve block (FNB) that is currently being rolled out locally as an alternative. During the implementation period of this new clinical routine, it will be possible to compare the efficacy of FICB and FNB in reducing participant-reported pain.

Interventions

Blind technique.

PROCEDUREFemoral Nerve Block

Ultrasound guided.

DRUGRopivacaine

Ropivacaine dosed according to local guidelines.

Sponsors

University Hospital, Linkoeping
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult emergency department patient over 18 years of age with a radiologically verified fracture classified as hip fracture that are eligible for a peripheral nerve block according to local guidelines

Exclusion criteria

* Multi-system trauma * Isolated pelvic or diaphyseal femur fracture * Patients unable to communicate regardless of reason * Patients with contraindications to receiving a peripheral nerve block with an amide local anaesthetic according to local guidelines

Design outcomes

Primary

MeasureTime frameDescription
Mean Change from Baseline in Pain Scores on the Numeric Rating Scale (0 to 10, where 10 is Maximum Pain) at 30 minutes after Administration of Block, at Rest and During Active Hip FlexionMeasured 30 minutes after administered nerve block.Change in reported pain score should be at least one whole unit on the numeric rating scale.

Secondary

MeasureTime frameDescription
Ratio of Failed BlocksThrough study completion, an average of 1 yearDefined by a failure to reduce reported pain 30 minutes after administered block by at least one whole unit on the numeric rating scale
Rate of ComplicationsThrough study completion, an average of 1 yearComparing the rate of any reported complication between cohorts

Countries

Sweden

Contacts

Primary ContactDaniel Leckström, MBBS
daniel.leckstrom@regionostergotland.se+46704555507
Backup ContactSofia Freland, PhD, MD
sofia.freland@regionostergotland.se+46705868671

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026